|
Satish Reddy
|
Indian Pharmaceutical Alliance (IPA) has appointed Satish Reddy, Vice Chairman and Managing Director of Dr Reddy’s Laboratories (DRL) as the President for 2013-15 and Nilesh Gupta, Managing Director, Lupin as the Vice President.
Reddy steers DRL’s Pharmaceutical Services & Active Ingredients (PSAI) and Global Generics businesses, two of the company’s core revenue generating streams. He joined DRL in 1993 as Executive Director responsible for manufacturing and new product development and became the Managing Director in 1997.
| Nilesh Gupta |
Reddy holds a degree in chemical engineering from Osmania University, India and an MS in medicinal chemistry from Purdue University, US. He has been the executive council member of the IPA, national council member of the Confederation of Indian Industry (CII), chairman of CII National committee on Drugs and Pharmaceuticals, served as member of the board of Drugs Technical Association Board (DTAB) of India and trustee of Dr Reddy’s Foundation (DRF).
Gupta joined Lupin in 1996 and has led the company’s research, supply chain, manufacturing, quality and regulatory operations. A chemical engineer from the ertswhile University Department of Chemical Technology, Mumbai, and an MBA from the Wharton School, he has not only been responsible for transforming Lupin’s research programme and expanding the company’s manufacturing operations, but also been instrumental in formulating and executing the core strategy that has helped Lupin emerge as a global speciality pharma major.
EP News Bureau – Mumbai